Scientists at the University of Virginia have discovered that microglia—the brain’s resident immune cells—act as microscopic traffic controllers, regulating blood flow through the tiniest vessels that feed our neurons.
This finding could reshape how doctors approach Alzheimer’s disease and other neurodegenerative conditions where compromised blood flow starves brain tissue of essential nutrients.
The research, published in Nature Communications, reveals that microglia use an enzyme called cyclooxygenase-1 (COX1) to maintain proper “tone” in capillaries—the hair-thin vessels that form the brain’s most extensive vascular network. When researchers eliminated these immune cells in mice, capillary diameter shrank by significant amounts and blood flow dropped by roughly 50%.
The Brain’s Energy Crisis
Our brains are metabolic powerhouses, consuming 20% of the body’s total energy despite weighing just 2% of our total body weight. This massive energy demand requires a sophisticated delivery system: 400 miles of blood vessels in the human brain, branching into countless capillaries that reach within 8-20 micrometers of every neuron.
“For some time now, microglia have been suggested to play important roles in regulating vessel function,” said Ukpong B. Eyo, the study’s senior author and researcher at UVA’s Center for Brain Immunology and Glia. “With this study, we have provided the most definitive evidence that they do regulate blood flow to the brain, specified the location of this function to the brain’s small vessels or capillaries and identified an enzyme that they use to do this.”
The research team used sophisticated imaging techniques to track individual microglia as they interacted with capillaries in living mouse brains. They discovered that roughly 65% of microglia cluster around capillaries, while other immune cells called perivascular macrophages primarily associate with larger vessels.
Key Research Findings
The Virginia team’s experiments revealed several crucial insights:
- Microglia express COX1 at levels ten times higher than astrocytes, the brain’s support cells
- Removing microglia causes immediate capillary constriction and reduced blood flow
- Genetic elimination of COX1 specifically in microglia produces identical vascular problems
- Restoring microglia populations reverses these blood flow deficits
Using a technique called 2Phatal ablation, researchers could eliminate individual microglia while observing real-time changes in nearby capillaries. “We observed significantly reduced capillary diameter following global ablation of microglia, which was restored to baseline values following microglial repopulation,” the researchers reported.
Alzheimer’s Connection
The findings carry particular significance for Alzheimer’s disease, where compromised blood flow has long been recognized as both a contributor and consequence of neurodegeneration. Previous studies have shown that COX1 inhibitors have produced mixed results in Alzheimer’s patients, but this research suggests timing may be crucial.
“The microglial enzyme identified in this study has been targeted heretofore in patients with Alzheimer’s disease, albeit with mixed results,” said William A. Mills III, the study’s first author. “Our study suggests that these therapeutics would have maximal benefit if prescribed according to the therapeutic window of microglia in Alzheimer’s—a focus in our ongoing research.”
The research challenges previous assumptions about which brain cells control vascular function. While astrocytes have traditionally been considered the primary regulators of blood flow, this study positions microglia as equally important players, particularly in maintaining baseline capillary tone.
Future Therapeutic Possibilities
The discovery opens several potential therapeutic avenues. Rather than simply targeting disease symptoms, treatments could focus on restoring microglial function to improve brain blood flow. This approach might benefit not only Alzheimer’s patients but also those with vascular dementia and certain forms of Parkinson’s disease.
“Although microglia are dysfunctional in neurodegenerative diseases, our work now raises the possibility of improving blood flow deficits by targeting microglia,” Eyo explained.
The research team identified several critical questions for future investigation: whether microglia work independently or coordinate with other brain cells, when during development this regulatory role begins, and whether replacing dysfunctional microglia could restore healthy blood flow in diseased brains.
The study was supported by multiple National Institutes of Health grants and represents part of UVA’s broader commitment to Alzheimer’s research, including the recently established Harrison Family Translational Research Center in Alzheimer’s and Neurodegenerative Diseases.
As researchers continue mapping the complex cellular networks that maintain brain health, this discovery highlights how immune cells serve not just as defenders against disease, but as essential partners in the brain’s fundamental life-support systems.
ScienceBlog.com has no paywalls, no sponsored content, and no agenda beyond getting the science right. Every story here is written to inform, not to impress an advertiser or push a point of view.
Good science journalism takes time — reading the papers, checking the claims, finding researchers who can put findings in context. We do that work because we think it matters.
If you find this site useful, consider supporting it with a donation. Even a few dollars a month helps keep the coverage independent and free for everyone.